NCT06978738 UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1
NCT06970951 Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06947473 Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. Status RECRUITING Phase PHASE1/PHASE2
NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH Status RECRUITING Phase PHASE1/PHASE2
NCT06925542 A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease Status RECRUITING Phase PHASE1
NCT06888973 Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT06775912 Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06733935 A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) Status RECRUITING Phase PHASE1/PHASE2
NCT06549296 Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases Status SUSPENDED Phase EARLY_PHASE1
NCT06548607 Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06546540 The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis Status RECRUITING Phase PHASE4
NCT06544343 Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy Status RECRUITING Phase NA
NCT06544330 A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06489652 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis Status NOT_YET_RECRUITING Phase PHASE1
NCT06472362 Chest CT Biomarkers as Prognostic Predictors in SSc-ILD Status ENROLLING_BY_INVITATION Phase N/A
NCT06462768 Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis Status RECRUITING Phase N/A
NCT06434363 Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders Status RECRUITING Phase PHASE1/PHASE2
NCT06420154 The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06417398 Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1